Physician profile
Alexander Kramer
NPI 1841923067
$2,585.29
in general payments reported to CMS, 2019-2025
14 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $91.32 · 2023: $446 · 2024: $989 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,493.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,470.58 | 2022-2025 | Ortholoc 3di, Valor, Augment Injectable |
| Biotissue Holdings INC. | $395.35 | 2024-2025 | |
| Smith+Nephew, INC. | $154.22 | 2024-2025 | Stravix, Renasys Touch |
| Penumbra, INC. | $148.75 | 2024 | Indigo System |
| Mimedx Group, INC. | $125.82 | 2024 | |
| Bioventus LLC | $58.68 | 2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $47.32 | 2023 | Truelok, Ankle Hindfoot Nailing System, Galaxy Fixation System |
| Solventum Corporation | $41.83 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Abbvie INC. | $31.95 | 2025 | |
| Flower Orthopedics Coporation | $25.50 | 2025 | |
| Polynovo North America LLC | $23.85 | 2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $22.95 | 2025 | Tcc-Ez |
| Amgen INC. | $19.45 | 2025 | Krystexxa |
| Depuy Synthes Sales INC. | $19.04 | 2023 | Na, N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.